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Gulfaraz KhanSummary
In September 2012, a novel coronavirus was isolated from a patient in Saudi Arabia who had died of an
acute respiratory illness and renal failure. The clinical presentation was reminiscent of the outbreak caused by
the SARS-coronavirus (SARS-CoV) exactly ten years ago that resulted in over 8000 cases. Sequence analysis of
the new virus revealed that it was indeed a member of the same genus as SARS-CoV. By mid-February 2013,
12 laboratory-confirmed cases had been reported with 6 fatalities. The first 9 cases were in individuals resident in the
Middle East, while the most recent 3 cases were in family members resident in the UK. The index case in the UK family
cluster had travel history to Pakistan and Saudi Arabia. Although the current evidence suggests that this virus is not
highly transmissible among humans, there is a real danger that it may spread to other parts of the world. Here, a brief
review of the events is provided to summarize the rapidly emerging picture of this new virus.
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Whenever a new virus associated with an acute respira-
tory illness emerges, medical authorities around the
world are put on high alert and vigilance, and quite jus-
tifiably. Emerging and re-emerging viruses causing re-
spiratory infections have been responsible for outbreaks
resulting in millions of deaths. The pandemic influenza
viruses of 1918, 1957 and 1968 are our bleak reminders.
Since 1968, major outbreaks with mortalities on the
scale previously seen have not occurred, although there
have been regular threats.The novel coronavirus
Recently, a novel coronavirus has been identified in
patients with severe acute respiratory illness [1,2]. This
new virus, provisionally referred to as novel coronavirus
(NCoV) has been fully sequenced and shown to belong
to group C β-coronaviruses [3-5]. The genome, which is
just over 30 KB, contains at least 10 predicted open
reading frames (ORFs) [4]. The genome size, organi-
zation and sequence analysis revealed that the NCoV is
most closely related to bat coronaviruses BtCoV-HKU4Correspondence: g_khan@uaeu.ac.ae
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reproduction in any medium, provided the orand BtCoV-HKU5 [3-5] first isolated in 2006 from bats
captured in Hong Kong [6]. The major difference bet-
ween NCoV and these bat coronaviruses is in the region
between the spike and the envelop genes [5]. The NCoV
has 5 ORFs while the bat viruses have 4 in this region
[5]. The nearest human coronavirus related to NCoV is
SARS-CoV [3-5]. This virus was responsible for the out-
break of severe acute respiratory syndrome in 2002–
2003 which resulted in 8,422 cases worldwide with 916
deaths [7]. With a mortality of approximately 11% seen
with SARS-CoV infection, the identification of NCoV
from patients with similar acute respiratory illness as
with SARS-CoV is of a real concern. Coronaviruses are a
large family of enveloped, single-stranded RNA viruses
that infect a number of different species, including
humans. They are usually species specific, however
interspecies transmission of coronaviruses can occur
[8-10]. Worryingly, in vitro studies show that NCoV is
also capable of infecting cells from different species, in-
cluding monkeys, humans, bats and pigs [2,11]. Indeed,
NCoV was first isolated using monkey kidney epithelial
cell lines, Vero and LLC-MK20, both of which are sus-
ceptible to infection and can propagate the virus rela-
tively easily [2]. Prior to the isolation of NCoV, only five
coronaviruses, namely 229E, OC43, SARS-CoV, HKU1
and NL63, were known to cause infections in humansis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of these coronaviruses, except for SARS-CoV, are ge-
nerally associated with mild upper respiratory tract
infections. SARS-CoV has an unusual predilection for
infecting cells in the lower respiratory tract. Although
NCoV also causes lower respiratory tract infection, the
viral receptor appears to be different from that used by
SARS-CoV [11,13].
Timeline for confirmed human cases (in
chronological order of reporting)
As of 15 February 2013, a total of 12 laboratory confirmed
cases of NCoV have been reported to WHO [14]. The first
9 of these cases have been from the Middle East: 5 cases
(3 fatal) from Saudi Arabia, 2 cases from Qatar and 2 cases
(both fatal) from Jordan (Figure 1). The most recent 3
cases (1 fatal) were in individuals living in UK.
20th September
The first reported case was in a 60-year old Saudi man. He
was admitted to hospital in the port city of Jeddah on 13th
June 2012 with a 7-day history of fever, cough and short-
ness of breath. He died 11-days later of progressiveFigure 1 Novel coronavirus timeline (chronology of reporting): Septe
details of the 12 laboratory confirmed cases of the novel coronavirus infectrespiratory and renal failure [2]. Laboratory investigations
for common causes of respiratory illness, including influ-
enza, parainfluenza, adenovirus and respiratory syncytial
virus were all negative [2]. However, inoculation of Vero
and LLC-MK2 cells with sputum sample taken on admis-
sion, resulted in cytopathic changes suggestive of viral in-
fection [2], which was eventually identified as a novel
coronavirus and reported on 20th September [15].22nd September
The second case was in a 49-year old Qatari patient [16].
He had a history of travel to Saudi Arabia from 31st July
to 18th August, but no evidence of contact to the first case
[16]. He developed a mild respiratory illness on 3rd of
September which progressed to pneumonia and he was
hospitalized in Doha on 9th September [17]. His condition
further deteriorated and he was transferred by air am-
bulance to London. Tests for common causes of his severe
respiratory illness were negative [17]. The report of the
isolation of a new coronavirus from the Saudi case led the
medical team to test for the new virus. The test came po-
sitive and the case was reported to the WHO on 22nd
September [18].mber 2012-February 2013. The figure summarizes some of the basic
ion and dates when these cases were officially reported.
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No new case was reported during October. Then in early
November, the Saudi Ministry of Health reported the
3rd case [19]. A 45-year old man was admitted to hospital
on 12th October with severe respiratory illness. He was
a heavy smoker with a number of underlying chronic
conditions, including type 2 diabetes, an atrophied right
kidney, and a history of ischaemic heart disease [20]. Over
the next few days, his condition deteriorated with progres-
sive pneumonia and renal failure and required mechanical
ventilation and hemodialysis. As with the previous two
cases, laboratory tests for common respiratory viruses
were all negative [20]. However, samples tested for NCoV
at three different laboratories, one in Jeddah and two
in UK, all returned positive. In spite of his underlying
conditions, by 27th October the patient's condition
had improved and he was eventually discharged on the
4th November.
19th November
The fourth case was announced by the Saudi Ministry of
Health on 19th November and published by ProMed-Mail
two days later [21]. The patient was admitted with respira-
tory illness and the novel coronavirus was suspected as a
possible cause. Samples were tested for the novel virus at
reference laboratories in Saudi Arabia and UK and re-
turned positive. The patient succumbed to his infection
and subsequently died from renal failure [22].
23rd November
On 23rd November, WHO reported 3 additional
confirmed cases, 1 from Qatar and 2 from Saudi Arabia
[23]. The Qatari man was initially admitted to a hospital
in Doha in October with severe respiratory illness,
but he was subsequently transferred to a hospital in
Germany. Laboratory results confirmed that he was
positive for the novel coronavirus. He remained in hos-
pital for approximately a month, but he recovered from
his respiratory and renal illness and was discharged in
the week of 18th November. The Saudi cases (cases 6
and 7) (Figure 1) are of particular interest as these were
from a single family and were related to case 4 [22]. All
3 cases lived in the same house [24] and it is believed
that case 4, a 70-year old man, was the index case in this
cluster. He is thought to have infected two of his sons,
one of whom (case 6) subsequently died of multi-organ
failure. A fourth case from this family also presented
with similar symptoms, but laboratory tests revealed that
it was not due to the novel coronavirus [24].
30th November
At the end of November, WHO reported that two cases
that had died of an unknown respiratory infection in April
2012 in Jordan were retrospectively tested for the newcoronavirus and found to be positive [25]. These cases
were part of a cluster of 11 cases, 8 of whom were
healthcare workers who presented with a severe respira-
tory illness that was unexplained at the time, but was noti-
fied to the WHO [25].
11-15th February: family cluster
On 11th February 2013, the UK Health Protection Agency
(HPA) confirmed a further case of the novel coronavirus
in a 60-year old UK resident [26]. The patient was admit-
ted to hospital on 31st January 2013 with severe lower re-
spiratory illness. Prior to his illness, he had travelled to
Pakistan (from 16th December to 20th January) and Saudi
Arabia (from 20th – 28th January 2013) [27]. It appears
that his illness developed while he was in Saudi Arabia.
Laboratory tests confirmed NCoV infection. Interestingly,
this patient was also co-infected with H1N1 2009 pan-
demic influenza [27]. At the time of writing this review
(15th February 2013) the patient was being treated in
intensive care (ICU).
A few days after the announcement of case 10, the
HPA confirmed the diagnosis of two further cases, one
on 13th February [28] and one of 15th February [29].
Both of these cases were family members of case 10 and
neither had any recent travel history. They appear to
have contracted the infection from their relative [30].
Case 11 was admitted to hospital on 9th February after a
short history of respiratory symptoms. The patient had
pre-existing medical conditions, which may have made
him more susceptible to respiratory infections [27]. On
19th February, the HPA reported that this patient suc-
cumb to his illness and died [31] Case 12 on the other
hand did not have any pre-existing medical conditions
and the latest reports indicate that she has recovered.
The HPA has also reported that they have identified and
followed up over 100 contacts of the cases in this cluster
and all have tested negative for novel coronavirus [31].
Source and mode of transmission
The original source of infection and mode of transmission
to humans is unclear. At least 2 cases were reported to
have visited farms and may have had contact with animals
[20,32]. Thus a zoonotic infection is a possibility. Further-
more, the fact that the NCoV is most closely related to bat
coronaviruses [3-5] indicates that it might have originated
from bats. Studies showing that SARS-CoV was most
likely to have derived from bats [33] also supports a zoo-
notic origin for this new coronavirus. However, it is un-
known whether the NCoV was transmitted to humans by
a direct interspecies jump or it involved another inter-
mediary animal. In the case of SARS-CoV, civet cats were
identified as a likely intermediate host [8,9,33]. Like
SARS-CoV, the exact natural reservoir species of the
NCoV also remains to be identified.
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appear to have had any contact with animals. Could there
be human-to-human transmission? The two clusters of
cases, one from a family in Saudi Arabia, the other from a
healthcare team at a hospital in Jordan and the most
recent UK cluster of cases certainly suggests that human-
to-human transmission is very likely. In the family cluster,
3 members contracted the infection. The index case is
thought to be a 70-year old grandfather admitted to a hos-
pital in Riyadh with severe respiratory illness. His two sons
took in turns to stay by him during his illness (Dr Ziad
Memish, personal communication). In spite of all suppor-
tive care, the patient died of renal failure. Both of his sons
subsequently also contracted the infection and one of
them died of multi-organ failure some days later. In the
Jordanian cluster, 11 cases (7 nurses and 1 doctor)
presented with an acute respiratory illness of unknown
aetiology in April 2012 [25]. Two of the cases subse-
quently died. Retrospective testing confirmed both cases
to be positive for the NCoV [34]. Investigations of the
non-fatal unconfirmed probable cases in this cluster
revealed that the illness in these cases was generally mild
[24]. Indeed, in one case, the symptoms were mild enough
to be managed at home. The cases in both, the Saudi and
Jordanian cluster had no reported contact with animals.
Similarly, the most recent laboratory confirmed cases
from UK (cases 11 and 12), also had no contact with
animals or any history of travel to the Middle East. Both
appear to have contracted the infection from a family
member who had recently returned from Saudi Arabia
[30]. Together, these anecdotal observations clearly indi-
cate that person-to-person infection, probably via respira-
tory mode of transmission, is highly plausible.
Based on the data we have so far, NCoV does not
appear to be highly infectious in humans. None of the
first 3 confirmed cases (2 Saudis, 1 Qatari) have been
associated with transmission of symptomatic disease to
close contacts [20,32]. Detailed follow-up of 64 close
contacts of the Qatari patient, which included healthcare
professionals, family members and friends, only 13
individuals developed respiratory symptoms, but none of
these cases were positive for NCoV [32]. This would
suggest that human-to-human transmission is limited.
Clinical features associated with the novel
coronavirus
All of the cases had one thing in common: they suffered
from severe respiratory illness which was not due to any
of the known viral or bacterial causes. The most com-
mon initial symptoms were reported to be fever, cough
and shortness of breath. Patients rapidly progressed to
severe pneumonia and renal failure. The latter presenta-
tion has not been seen in all patients. For examples,
none of the cases in the Jordanian cluster had renalfailure [24]. The two fatal cases in this cluster, one
developed pericarditis and the other had disseminated
intravascular coagulation [24]. Coronaviruses predomi-
nantly cause mild self-limiting upper respiratory tract
infections. The only other human coronavirus that is
associated with severe lower respiratory infection is
SARS-CoV [35]. However, in contrast to SARS-CoV
[36,37], this novel coronavirus does not appear to cause
diarrhea. Of 12 laboratory confirmed cases, 6 have died
and 1 is currently in ICU. This would imply a relatively
high mortality rate. However, caution has to be exer-
cised, since we do not know the true prevalence of infec-
tion with NCoV. It is possible that in some cases, the
virus is associated with mild respiratory tract infection
which goes unseen and only those patients who develop
severe disease seek medical attention. It is also worth
noting that all of laboratory confirmed cases have been
adults.
Diagnosis of the novel coronavirus
The novel coronavirus can be cultured from sputum
samples using monkey kidney cells, Vero and LLC-MK2
cells. Viral induced cytopathic changes are seen in these
cells within 1–2 weeks of infection [2]. However, these
changes are not specific for NCoV and confirmation
using reverse transcription PCR (RT-PCR) is required.
RT-PCR can also be performed directly on clinical
samples such as respiratory swabs. An optimized real-
time RT-PCR protocol for the specific detection of
NCoV has been developed and is available [1]. Further-
more, an additional confirmatory RT-PCR assay and a
serological test using convalescent patient serum has
been established [38].
Concluding remarks
The emergence of any novel virus, in particular one that
can be transmitted via the respiratory route, has to be
taken seriously. A rapid response, a united global front
and mobilization of resources and expertise are our best
tools in preventing or reducing the devastation that
some of these viruses can cause. This is exemplified by
the recent events that have led to the recognition and
isolation of the novel coronavirus responsible for acute
respiratory illness. Within weeks of the first report, a
PCR-based diagnostic assay was made available [1], a
preliminary case definition [39] and incubation period
was issued [40], the virus was fully sequenced [4], the
detection of new cases was rapidly communicated to the
health authorities and more recently, guidelines for
handling and working with this virus have been issued
[24]. The novel coronavirus is the 6th member of the
human coronaviruses and the third to be isolated in the
last ten years. Based on current information, NCoV does
not appear to transmit easily or sustainably between
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infection and renal failure. The mode of transmission
has not been conclusively identified, although respiratory
route looks most likely. A study which is in press, has
shown that a number of different bat species resident in
Ghana and parts of Europe are infected with coro-
naviruses very similar to NCoV, in some cases differing
by less than 2% at the genetic level [41]. These findings
suggest that NCoV is most likely to have arisen from bat
viruses. However, a number of pertinent questions re-
main unanswered: Does NCoV represent an interspecies
jump of a bat coronavirus? How did humans acquired
the infection? Was it a direct infection from bats to
humans or did it involve an intermediate host such as
domestic animals? Are the virus isolates from all infec-
ted persons genetically identical? Do NCoV genetic
variants exits in the human population, but cause mild
or asymptomatic infections? Future studies will no doubt
attempt to address these and other related questions.
For the time being, surveillance and thorough inves-
tigations of cases with unexplained severe respiratory ill-
ness, particularly in those residing in or returning from
Middle East, is being recommended [24].
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